SCHEMBL13282020

SCHEMBL13282020

NS(=O)(=O)c1ccn(-c2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 16/20 0.56
CA2 P00918 16/20 0.56
CA12 O43570 14/20 0.56
CA9 Q16790 14/20 0.56
CA7 P43166 3/20 0.50
CA4 P22748 2/20 0.50
CA5A P35218 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
CA14 Q9ULX7 2/20 0.50
COMT P21964 2/20 0.50
CA3 P07451 1/20 0.50
CA6 P23280 1/20 0.50
PLA2G7 Q13093 1/20 0.50
CA13 Q8N1Q1 1/20 0.50
SOS1 Q07889 1/20 0.40
PTGS2 P35354 2/20 0.40
SCN2A Q99250 1/20 0.40
PTGS1 P23219 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29179024 0.81 CA1 (0.53) CA1CA2CA12CA9CA7
SCHEMBL29179059 0.81 CA1 (0.53) CA1CA2CA12CA9CA7
SCHEMBL3422896 0.70 CA2 (0.54) CA1CA2CA12CA9CA7
SCHEMBL10079423 0.70 KDM4E (0.53) CA1CA2CA12CA9CA7
SCHEMBL2771870 0.69 CA2 (0.56) CA1CA2CA12CA9CA7
Benzenesulfonamide SCHEMBL729 0.69 CA2 (1.00) CA1CA2CA12CA9CA7
Benzenesulfonamide SCHEMBL6868390 0.69 CA2 (1.00) CA1CA2CA12CA9CA7
SCHEMBL19479299 0.69 CA2 (1.00) CA1CA2CA12CA9CA7
Benzenesulfonamide SCHEMBL1332409 0.69 CA2 (1.00) CA1CA2CA12CA9CA7
Benzenesulfonamide SCHEMBL29825137 0.69 CA2 (1.00) CA1CA2CA12CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2697197-A1 PYRROLO SULFONAMIDE COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORGAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES Phenex Pharmaceuticals AG (DE) 2014-02-19 EP disclosed
WO-2012139775-A1 PYRROLO SULFONAMIDE COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORGAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES PHENEX PHARMACEUTICALS AG (DE) 2012-10-18 WO disclosed